Latest News and Press Releases

NEW YORK, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Quit Genius, the world’s first digital clinic for treating multiple substance addictions, today announced results from a pilot study of integrated alcohol...

Alight clients will have access to Quit Genius’ evidence-based tobacco cessation programs through Alight Worklife® NEW YORK, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Quit Genius, the world’s first digital...

NEW YORK, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Two additional solutions by Quit Genius, the world’s first digital clinic for treating multiple substance addictions, have been added to the Evernorth...

NEW YORK, Aug. 31, 2022 (GLOBE NEWSWIRE) -- A new survey finds 1 in 5 American workers believes substance use has impacted their work performance. The survey of 1,000+ American workers was conducted...

NEW YORK, July 13, 2022 (GLOBE NEWSWIRE) -- Quit Genius, the world’s first digital clinic for treating multiple substance addictions, announced today that it has moved to a new...

NEW YORK, May 19, 2022 (GLOBE NEWSWIRE) -- Quit Genius, the world’s first digital clinic for treating multiple substance addictions, announced today that its co-founder and Chief Product Officer...

NEW YORK, May 05, 2022 (GLOBE NEWSWIRE) -- Quit Genius, the world’s first digital clinic for treating multiple substance addictions, announced today that a new study published in Nicotine &...

NEW YORK, May 03, 2022 (GLOBE NEWSWIRE) -- Quit Genius, the world’s first digital clinic for treating multiple substance addictions, announced today that it has received Honorable Mention in Fast...

NEW YORK, April 13, 2022 (GLOBE NEWSWIRE) -- Quit Genius, the world’s first digital clinic for treating multiple substance addictions, announced today that it has earned its LegitScript...

NEW YORK and DALLAS, April 06, 2022 (GLOBE NEWSWIRE) -- Quit Genius, the world’s first digital clinic for treating multiple substance addictions, and Evry Health, a modern business-to-business...